Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Don’t Let a Change In Washington Change Your Opinion on Palantir Stock

Palantir is not a revenue giant compared to some of its peers, but there appears to be a growth narrative in place for Palantir stock.

Without Transparency Luckin Cofee Stock Is Not Viable

A lack of transparency about the state of its business should make investors rightfully concerned about the viability of Luckin Coffee stock.

XPeng Is Charged With Potential, but Profit Is Years Away

XPeng is one of the latest EV stocks to go public. The company is loaded with potential, but with profit years away XPEV stock looks overpriced.

Aurora Cannabis Can’t Grow Its Way to a Profit

Aurora Cannabis opted for growth when it didn't need to. Now it needs to grow, but can't stop burning cash That's not a good story for ACB stock.

3 Solar Stocks to Buy as India Goes Greener

While many investors are eyeing a solar boom in the United States, these 3 solar stocks are helping India continue to get lean and green.

Bulls of Sundial Growers Stock Are Ignoring Reality

The hope that marijuana will become legal in the U.S. is elevating hope that Sundial Growers stock will be an undervalued gem. But traders need to face reality.

You Need More Than Patience to Buy American Airlines

The hope of a Covid-19 vaccine is creating a vaccine rally. But investors should base their decision to buy AAL stock on where it was before the pandemic.

Now Is Not the Time to Load Up on FuelCell Stock

FCEL stock is surging from what a Biden presidency may mean for renewable energy. But hydrogen fuel cells may not be ready to meet the moment.

Workhorse Remains a Speculative Buy With a Capital ‘S’

Workforce competes in an attractive EV niche. But with the status of a major contract likely not decided for six months, WKHS stock remains a speculative buy.

Avoid Boosting the Vaccine Premium on Delta Air Lines Stock

Airline stocks are rising on Covid-19 vaccine hopes. But with a return to normal years away, investors are paying a premium for DAL stock.